Upwards arrow: Go back to top

Join us on LinkedIn for the latest news.

News & Press

Learn more about recent advances in biotech, health tech and our work.

Cleara Biotech Appoints CMO
22.2.2023
Cleara Biotech Appoints Nicholas J. Sarlis, MD, PhD as Chief Medical Officer and Head of Clinical Development
Cleara Raises Financing
28.9.2022
Cleara Biotech Raises $2.5 Million in Seed Financing to Advance FOXO4-Therapeutics Pipeline for Treating Cancer and Chronic Diseases
Auron Therapeutics Announces Series A
20.7.2022
Auron Therapeutics Announces $48 Million Series A Financing to drive novel oncology pipeline leveraging a machine learning, multi-omics based platform
Haya Therapeutics Among Top Biotech Investments
13.4.2022
Haya Therapeutics, backed by Apollo since March 2021, listed among Europe's top biotech investments
Interview with the Apollo Health Ventures Team
18.3.2022
Interview with the Apollo Health Ventures Team
Haya Therapeutics raises Seed extension round and expands to San Diego
11.2.2022
Haya Therapeutics raises Seed extension round and expands to San Diego
Apollo closes $180 Million Fund
1.12.2021
Apollo Health Ventures Closes $180 Million Fund to Drive Breakthrough Innovations Combating Age-related Diseases